, Volume 184, Issue 1, pp 1–12 | Cite as

Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning

  • C. L. Patti
  • S. R. Kameda
  • R. C. Carvalho
  • A. L. Takatsu-Coleman
  • G. B. Lopez
  • S. T. Niigaki
  • V. C. Abílio
  • R. Frussa-Filho
  • R. H. Silva
Original Investigation



The amnesic effects of morphine may be related to its action on nociception, anxiety, or locomotion. This effect is also suggested to be related to state dependency.


The aims of this study were to verify the effects of morphine on mice tested in the plus-maze discriminative avoidance task (DAT) that uses light and noise as aversive stimuli and allows the concomitant evaluation of learning, memory, anxiety, and locomotion and also to verify the possible role of state-dependent learning in the effects of morphine.

Methods and results

The DAT was conducted in a modified elevated plus-maze. In the training, the aversive stimuli were applied when mice entered in one of the enclosed arms, whereas in the test, no stimuli were applied. The main results showed that (1) pretraining morphine (5–20 mg/kg i.p.) induced retrieval deficits (evaluated by the time spent in the aversive arm in the test) but not acquisition deficits (evaluated by the decrease in aversive arm exploration along the training); (2) pretest morphine (5–10 but not 20 mg/kg) counteracted this deficit; (3) morphine induced hypolocomotion (decreased number of entries in the arms), irrespective of memory alterations; and (4) morphine did not alter anxiety-like behavior (evaluated by the time spent in the open arms) during the training.


Morphine given before training induces retrieval deficits in mice tested in the DAT, and these deficits could be related to morphine-induced state-dependent learning. Neither the memory deficit induced by pretraining morphine nor the reversal of this deficit by pretest morphine seems to be related to anxiety levels or locomotor alterations.


Avoidance paradigms Morphine State dependence Memory Anxiety Mice 


  1. Aguilar MA, Miñarro J, Simón VM (1998) Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol Learn Mem 69:92–105PubMedCrossRefGoogle Scholar
  2. Aguilar MA, Mari-Sanmillán MI, Morant-Deusa JJ, Miñarro J (2000) Different inhibition of conditioned avoidance response by clozapine and DA D1 and D2 antagonists in male mice. Behav Neurosci 114:398–400CrossRefGoogle Scholar
  3. Aguilar MA, Miñarro J, Simón VM (2004) Morphine potentiates effects of neuroleptics on two-way active conditioned avoidance response in male mice. Prog Neuropsychopharmacol Biol Psychiatry 28:225–237PubMedCrossRefGoogle Scholar
  4. Anseloni V, Coimbra NC, Morato S, Brandão MA (1999) A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test. Exp Brain Res 129:260–268PubMedCrossRefGoogle Scholar
  5. Babbini M, Davis W (1972) Time–dose relationships for locomotor activity effects of morphine after acute or repeated treatment. Br J Pharmacol 46:213–224PubMedGoogle Scholar
  6. Belzung C, Agmo A (1997) Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice. Eur J Pharmacol 323:133–136PubMedCrossRefGoogle Scholar
  7. Boyer JS, Morgan MM, Craft RM (1998) Microinjection of morphine into the rostral ventromedial medulla produces greater antinociception in male compared to female rats. Brain Res 796(1–2):315–318PubMedCrossRefGoogle Scholar
  8. Bruins Slot LA, Colpaert FC (1999a) Opiate states of memory: receptor mechanisms. J Neurosci 19:10520–10529PubMedGoogle Scholar
  9. Bruins Slot LA, Colpaert FC (1999b) Recall rendered dependent on an opiate state. Behav Neurosci 113:337–344PubMedCrossRefGoogle Scholar
  10. Bruins Slot LA, Koek W, Colpaert FC (1999) Ethanol state dependence involving a lever press response requirement in rats. Behav Pharmacol 10(2):229–33PubMedCrossRefGoogle Scholar
  11. Calzavara MB, Lopez GB, Abílio VC, Silva RH, Frussa-Filho R (2004) Role of anxiety levels in memory performance of spontaneously hypertensive rats. Behav Pharmacol 15(8):545-553PubMedCrossRefGoogle Scholar
  12. Calzavara MB, Patti CL, Lopez GB, Abilio VC, Silva RH, Frussa-Filho R (2005) Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice. Life Sci 76(19):2235–2246PubMedCrossRefGoogle Scholar
  13. Castellano C, Cestari V, Cabib S, Puglisi-Alegra S (1994) The effects of morphine on memory consolidation in mice involve both D1 and D2 dopamine receptors. Behav Neural Biol 61(2):156–161PubMedCrossRefGoogle Scholar
  14. Cestari V, Castellano C (1997) MK-801 potentiates morphine-induced impairment of memory consolidation in mice: involvement of dopaminergic mechanisms. Psychopharmacology (Berl) 133(1):1–6CrossRefGoogle Scholar
  15. Claro FT, Silva RH, Frussa-Filho R (1999) Bovine brain phosphatidylserine attenuates scopolamine-induced amnesia. Physiol Behav 67(4):551–554PubMedCrossRefGoogle Scholar
  16. Colpaert FC (1990) Amnestic trace locked into the benzodiazepine state of memory. Psychopharmacology 102:28–36PubMedCrossRefGoogle Scholar
  17. Colpaert FC (1996) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 47:605–629Google Scholar
  18. Colpaert FC, Koek W, Bruins Slot LA (2001) Evidence that amnesic state govern normal and disordered memory. Behav Pharmacol 12(8):575–589PubMedGoogle Scholar
  19. Conceição IM, Maiolini M Jr, Mattia NF, Chang YH, Smaili S, Frussa-Filho R (1994) Effect of withdrawal from long-term nifedipine administration on open-field habituation in the rat. Braz J Med Biol Res 27:1363–1367PubMedGoogle Scholar
  20. Costanzi M, Battaglia M, Rossi-Arnaud C, Castellano C (2004) Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms. Neurobiol Learn Mem 81(2):144–149PubMedCrossRefGoogle Scholar
  21. Festing MFW (1993) International index of laboratory animals, vol 6. University of Leicester, LeicesterGoogle Scholar
  22. File SE (1990) One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology 100:281–282PubMedCrossRefGoogle Scholar
  23. File SE (1993) The interplay of learning and anxiety in the elevated plus-maze. Behav Brain Res 58:199–202PubMedCrossRefGoogle Scholar
  24. Frussa-Filho R, Ribeiro RA (2002) One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sci 71:519–525PubMedCrossRefGoogle Scholar
  25. Frussa-Filho R, Otoboni JR, Uema FT, Sá-Rocha LC (1991) Evaluation of memory and anxiety in rats observed in the elevated plus-maze: effects of age and isolation. Braz J Med Biol Res 24(7):725–728PubMedGoogle Scholar
  26. Frussa-Filho R, Barbosa-Júnior H, Silva RH, da Cunha C, Mello CF (1999) Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments. Psychopharmacology 147:168–173PubMedCrossRefGoogle Scholar
  27. Goto SH, Conceição IM, Ribeiro RA, Frussa-Filho R (1993) Comparison of anxiety measured in the elevated plus-maze, open-field and social interaction tests between spontaneously hypertensive rats and Wistar EPM-1 rats. Braz J Med Biol Res 26(9):965–969PubMedGoogle Scholar
  28. Havemann U, Winkler M, Kuschinsky K (1982) Is morphine-induced akinesia related to inibition of reflex activation of flexor alpha-motoneurones? Role of nucleus accumbens. Naunyn Schmiedebergs Arch Pharmacol 320(2):101–104PubMedCrossRefGoogle Scholar
  29. Holmes A, Rodgers RJ (1999) Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23:971–980PubMedCrossRefGoogle Scholar
  30. Hynes MD, Berkowitz BA (1983) Catecholamine mechanisms in the stimulation of mouse locomotor activity by the nitrous oxide and morphine. Eur J Pharmacol 90(1):109–114PubMedCrossRefGoogle Scholar
  31. Izquierdo I (1979) Effect of naloxone and morphine on various forms of memory in the rat: possible role of opiate mechanisms in memory consolidation. Psychopharmacology 66(2):199–203PubMedCrossRefGoogle Scholar
  32. Izquierdo I (1982) The role of an endogenous amnesic mechanism mediated by brain beta-endorphin in memory modulation. Braz J Med Biol Res 15(2–3):119–134PubMedGoogle Scholar
  33. Izquierdo I, Dias RD (1983) Effect of ACTH epinephrine beta-endorphine naloxone and of the combination of naloxone or beta-endorphine with ACTH or epinephrine on memory consolidation. Psychoneuroendocrinology 8:81–87PubMedCrossRefGoogle Scholar
  34. Izquierdo I, Dias RD, Carrasco MA, Elizabetsky E, Perry ML (1980) The role of opioid peptides in memory and learning. Behav Brain Res 1(6):451–468PubMedCrossRefGoogle Scholar
  35. Izquierdo I, Perry ML, Dias RD, Souza DO, Elizabetsky E, Carrasco MA, Orsingher OA, Netto CA (1981) Endogenous opioids memory modulation and state dependency. In: Martinez JL, Jensen RA, Messing RB, Rigter H, McGaugh JL (eds) Endogenous peptides and learning and memory process. Academic, New York, pp 269–290Google Scholar
  36. Jackson A, Koek W, Colpaert FC (1992) NMDA antagonists make learning and recall state-dependent. Behav Pharmacol 3(4):415–421PubMedCrossRefGoogle Scholar
  37. Jafari MR, Zarrindast MR, Djahanguiri B (2004) Effects of different doses of glucose and insuline on morphine state-dependent memory of passive avoidance in mice. Psychopharmacology 175:457–462PubMedGoogle Scholar
  38. Johnson DW, Glick SD (1993) Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats. Pharmacol Biochem Behav 46:341–347PubMedCrossRefGoogle Scholar
  39. Kalinichev M, White DA, Holtzman SG (2004) Individual differences in locomotor reactivity to a novel enviroment and sensitivity to opioid drugs in the rat. I. Expression of morphine-induced locomotor sensitisation. Psycopharmacology 177(1–2):61–67CrossRefGoogle Scholar
  40. Khavandgar S, Homayon H, Torkaman-Boutoabi A, Zarrindast MR (2002) The effects of adenosine receptors agonists and antagonists on morphine state-dependent memory of passive avoidance. Neurobiol Learn Mem 78:390–405PubMedCrossRefGoogle Scholar
  41. Khavandgar S, Homayon H, Zarrindast MR (2003) The effect of L-NAME and l-arginine on impairment of memory formation and state-dependent learning induced by morphine in mice. Psychopharmacology 167:291–296PubMedGoogle Scholar
  42. Kõks S, Soosaar A, Võikar V, Bourin M, Vasar E (1999) BOC-CCK-4 CCKB receptor agonist antagonizes anxiolytic-like action of morphine in elevated plus-maze. Neuropeptides 33:63–69PubMedCrossRefGoogle Scholar
  43. Kosten TA, Bombace JC (2000) Prior and delayed applications of dizocilpine or ethanol alter locomotor sensitization to morphine. Brain Res 878:20–31PubMedCrossRefGoogle Scholar
  44. Kuribata H (1995) Modification of morphine sensitisation by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 275(3):251–258PubMedCrossRefGoogle Scholar
  45. Kuzmin A, Sandin J, Terenius L, Ogren SO (2000) Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice. J Pharmacol Exp Ther 295(3):1031–1042PubMedGoogle Scholar
  46. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92(2):180–185PubMedCrossRefGoogle Scholar
  47. McGaugh JL, Baratti CM (1985) Pharmacological evidence of a central effect of naltrexone morphine and beta-endorphin and a peripheral effect of met- and leu-enkephalin on retention of an inhibitory response in mice. Behav Neural Biol 44:434–446PubMedCrossRefGoogle Scholar
  48. McNay EC, Gold PE (1998) Memory modulation across neural systems: intra-amygdala glucose reverses deficits caused by intraseptal morphine on a spatial task but not on an aversive task. J Neurosci 18:3835–3858Google Scholar
  49. Mohammad-Reza Z, Rezayof A (2004) Morphine sate-dependent learning: sensitization and interactions with dopamine receptors. Eur J Pharmacol 497:197–204PubMedCrossRefGoogle Scholar
  50. Mohammad-Reza Z, Eidi M, Eidi A, Oryan S (2002) Effects of histamine and opioid systems on memory retention of passive avoidance learning in rats. Eur J Pharmacol 425:193–197Google Scholar
  51. Moser PC (1989) An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology 99(1):48–53PubMedCrossRefGoogle Scholar
  52. Motta V, Brandão ML (1993) Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 44:119–125CrossRefPubMedGoogle Scholar
  53. Nishimura M, Shigi Y, Kaneto H (1990) State-dependent and/or direct memory retrieval by morphine in mice. Psychopharmacology 100:27–30CrossRefPubMedGoogle Scholar
  54. Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploration in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24(3):525–529CrossRefPubMedGoogle Scholar
  55. Pereira JKD, Vieira RJ, Konishi CT, Ribeiro RA, Frussa-Filho R (1999) The phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci 65:101–107CrossRefGoogle Scholar
  56. Ragozzino ME, Gold PE (1994) Task-dependent effects of intra-amygdala morphine injections: attenuation by intra-amygdala glucose injections. J Neurosci 14:7478–7485PubMedGoogle Scholar
  57. Ragozzino ME, Gold PE (1995) Glucose injections into the medial septum reverse the effect of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience 68:981–988CrossRefPubMedGoogle Scholar
  58. Ragozzino ME, Parker ME, Gold PE (1992) Spontaneous alteration and inhibitory avoidance impairment with morphine injections into the medial septum: attenuation by glucose administration. Brain Res 597:241–249CrossRefPubMedGoogle Scholar
  59. Roberts DC, Mason ST, Fibiger HC (1978) 6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy. Eur J Pharmacol 52:209–214CrossRefPubMedGoogle Scholar
  60. Rodgers RJ, Johnson NJ, Hodgson TP (1997) Resistance of experientially-induced in murine plus-maze behaviour to altered retest conditions. Behav Brain Res 86:71–77CrossRefPubMedGoogle Scholar
  61. Saha N, Datta H, Sharma PL (2001) Effects of morphine on memory: interactions with naloxone propranolol and haloperidol. Pharmacology 42(1):10–14CrossRefGoogle Scholar
  62. Saito H (1990) Inhibitory and stimulatory effects of morphine on locomotor activity in mice: biochemical and behavioral studies. Pharmacol Biochem Behav 35:231–235CrossRefPubMedGoogle Scholar
  63. Sasaki K, Fan LW, Tien LT, Ma T, Loh HH, Ho IK (2002) The interaction of morphine and gama-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain Res Bull 57:689–694CrossRefPubMedGoogle Scholar
  64. Schunr P, Bravo F, Trujillo M, Rocha S (1983) Biphasic effects of morphine on locomotor activity in hamsters. Pharmacol Biochem Behav 18:357–361CrossRefPubMedGoogle Scholar
  65. Shiigi Y, Kaneto H (1990) Facilitation of memory retrieval by pre-test morphine and its state dependency in the step-through type passive avoidance learning test in mice. Jpn J Pharmacol 54:79–81PubMedCrossRefGoogle Scholar
  66. Shin IC, Kim HC, Swanson J, Hong JT, Oh KW (2003) Anxiolytic effects of acute morphine can be modulated by nitric oxide systems. Pharmacology 68:183–189CrossRefPubMedGoogle Scholar
  67. Silva RH, Frussa-Filho R (2000) The plus-maze discriminative avoidance task: a new model to study memory–anxiety interactions. Effects of chlordiazepoxide and caffeine. J Neurosci Methods 102:117–125CrossRefPubMedGoogle Scholar
  68. Silva RH, Frussa-Filho R (2002) Naltrexone potentiates both amnestic and anxiolytic effects of chlordiazepoxide in mice. Life Sci 72:721–730CrossRefPubMedGoogle Scholar
  69. Silva RH, Felicio LF, Nasello AG, Vital MABF, Frussa-Filho R (1996) Effect of ganglioside (GM1) on memory in senescent rats. Neurobiol Aging 17(4):583–586CrossRefPubMedGoogle Scholar
  70. Silva RH, Bellot RG, Vital MABF, Frussa-Filho R (1997) Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. Psychopharmacology 129:322–328PubMedGoogle Scholar
  71. Silva RH, Felicio LF, Frussa-Filho R (1999) Ganglioside GM1 atenuates scopolamine-induced amnesia in rats and mice. Psychopharmacology 141:111–117CrossRefPubMedGoogle Scholar
  72. Silva RH, Bergamo M, Frussa-Filho F (2000) Effects of neonatal ganglioside GM1 administration on memory in adult and old rats. Pharmacol Toxicol 87:120–125CrossRefPubMedGoogle Scholar
  73. Silva RH, Kameda SR, Carvalho RC, Rigo GS, Costa KLB, Taricano ID, Frussa-Filho R (2002a) Effects of amphetamine on the plus-maze discriminative avoidance task in mice. Psychopharmacology 160:9–18CrossRefPubMedGoogle Scholar
  74. Silva RH, Abílio VC, Torres-Leite D, Bergamo M, Chinen CC, Claro FT, Carvalho RC, Frussa-Filho R (2002b) Concomitant developement of oral dyskinesia and memory deficits in reserpine-treated male and female mice. Behav Brain Res 132:171–177CrossRefPubMedGoogle Scholar
  75. Silva RH, Chein AB, Kameda SR Takatsu-Coleman AL, Abílio VC, Tufik S, Frussa-Filho R (2004a) Effects of pre- or post-training paradoxical sleep deprivation on two animal models of learning and memory in mice. Neurobiol Learn Mem 82:90–98CrossRefPubMedGoogle Scholar
  76. Silva RH, Kameda SR, Carvalho RC, Takatsu-Coleman AL, Niigaki ST, Abílio VC, Tufik S, Frussa-Filho R (2004b) Anxiogenic effect of sleep deprivation in the elevated plus-maze test in mice. Psychopharmacology 176:115–122CrossRefPubMedGoogle Scholar
  77. Spanagel R (1995) Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70(1):37–49PubMedCrossRefGoogle Scholar
  78. Stevens KE, Mickley GA, McDermott LJ (1986) Brain areas involved in production of morphine-induced locomotor hyperactivity of the C57B1/6J mouse. Pharmacol Biochem Behav 24(6):1739–1747PubMedCrossRefGoogle Scholar
  79. Timar J, Gyarmati Z, Fursti Z (2005) The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine. Brain Res Bull 64(5):417–424PubMedCrossRefGoogle Scholar
  80. Vaccarino AL, Oslon GA, Oslon RD, Kastin AJ (1998) Endogenous opiates. Peptides 20:1527–1574CrossRefGoogle Scholar
  81. Vakili A, Tayebi K, Jafari MR, Zarrindast MR, Djahanguiri B (2004) Effect of ethanol on morphine state-dependent learning in the mouse: involvement of GABAergic opioidergic and cholinergic systems. Alcohol Alcohol 39:427–432PubMedGoogle Scholar
  82. Vasko MR, Domino EF (1978) Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in rat. J Pharmacol Exp Ther 207:848–858PubMedGoogle Scholar
  83. Vinader-Caerols C, Aguilar MA, Perez-Iranzo N, Miñarro J, Parra A, Simón VM (1996) Apparent vs real effects of scopolamine on the learning of an active avoidance task. Neurobiol Learn Mem 66:246–251CrossRefPubMedGoogle Scholar
  84. Vivian JA, Miczek KA (1998) Effects of mu and delta opioid agonist and antagonists on affective vocal and reflexive pain response during social stress in rats. Psychopharmacology 139(4):364–375CrossRefPubMedGoogle Scholar
  85. Vivian JA, Miczek KA (1999) Interactions between social stress and morphine in the periaqueductal gray: effects on affective vocal and reflexive pain response in rats. Psychopharmacology 146(2):153–161CrossRefPubMedGoogle Scholar
  86. Walter S, Kuschinsky K (1989) Conditioning of morphine-induced locomotor activity and stereotyped behaviour in rats. J Neural Transm Gen Sect 78:231–247CrossRefPubMedGoogle Scholar
  87. Woolfe G, MacDonald AD (1944) The evaluation of the analgesic action pethidine hydrochloride (demerol). J Pharmacol Exp Ther 80:300–307Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • C. L. Patti
    • 1
  • S. R. Kameda
    • 1
  • R. C. Carvalho
    • 1
  • A. L. Takatsu-Coleman
    • 1
  • G. B. Lopez
    • 1
  • S. T. Niigaki
    • 1
  • V. C. Abílio
    • 1
  • R. Frussa-Filho
    • 1
  • R. H. Silva
    • 1
  1. 1.Department of PharmacologyUniversidade Federal de São PauloSão PauloBrazil

Personalised recommendations